UNSPSC 51112613: Tauromustine
Commodity
Code facts
- Part of
-
-
51000000
-
51110000
- 51112600
-
51110000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51112613
| NIGP code |
|---|
| 26910 Antineoplastic Agents |
Definition
This classification denotes a nitrosourea compound with the molecular formula C7H15ClN4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 511F69K76Y, chemically known as 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-n,n-dimethylethanesulfonamide but more generally known as tauromustine, which bears US NIH Compound Identifier 55456. European Medicines Agency schedules Tauromustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10838MIG.
Read the full definition
The term TAUROMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). TAUROMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tauromustine under HS 29350090 and SITC 51580. As of Q4 2014, TAUROMUSTINE remains US FDA's Preferred Term for this commodity. Tauromustine bears US NLM identifiers UMLS ID C0044133 and NCI Concept Code C954. SMILES: CLCCN(N=O)C(=O)NCCS(=O)(=O)N(C)C.
About UNSPSC 51112613
UNSPSC 51112613 Tauromustine (Commodity) covers pharmaceutical products sourced through direct-to-manufacturer prescription programs and specialty pharmacy channels that state and local health agencies are evaluating for inclusion in their benefit management and drug procurement strategies. State and local governments under this code are exploring ways to establish direct contractual relationships with pharmaceutical manufacturers and specialty vendors to bypass traditional pharmacy benefit managers and group purchasing organizations, seeking to improve cost management and prescription fulfillment efficiency for state employee health plans and Medicaid populations. The Texas Health and Human Services Commission is the primary recent issuing body, using exploratory mechanisms such as Requests for Information to gather vendor capabilities and market intelligence before committing to formal procurement vehicles.
The Texas HHS Commission posted Request for Information RFI HHS0017013 on April 3, 2026, with the same response deadline, seeking vendor experience with direct contracting for self-insured employers and government health plans, negotiated net pricing models without rebates, and value-based or outcomes-based agreements. The RFI is preliminary market intelligence rather than a binding competitive solicitation, designed to inform the state's future procurement strategy before issuing a formal RFP with established financial and temporal parameters. No award value or budget range is identified at this stage. Geographic activity under the code is currently limited to Texas; no other state or local opportunities appear in recent procurement notices.
Quick answers
What is UNSPSC 51112613?
UNSPSC 51112613 is Tauromustine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51112613?
UNSPSC 51112613 maps to 1 NIGP code, 26910 Antineoplastic Agents.
On GovTribe
See everything under UNSPSC 51112613
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code